JNJ-61803534 [1917306-14-9]

TargetMol Chemicals

JNJ-61803534 [1917306-14-9]

72

Research Use Only

JNJ-61803534

C23H23Cl2F6N3O4S

622.41

JNJ-61803534 is a potent, orally active RORgammat inverse agonist, demonstrating anti-inflammatory activity through inhibition of IL-17A production in human CD4+ T cells under Th17 differentiation conditions, with an IC50 of 9.6 nM.

3 years

C[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(c(Cl)c1Cl)C(O)(C(F)(F)F)C(F)(F)F)C(=O)NCC(C)(C)O

-20°C

12352200